chrX-138635576-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PP3_ModerateBS2
The NM_004114.5(FGF13):c.482G>A(p.Arg161His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000663 in 1,206,960 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 4 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0000090 ( 0 hom., 0 hem., cov: 23)
Exomes 𝑓: 0.0000064 ( 0 hom. 4 hem. )
Consequence
FGF13
NM_004114.5 missense
NM_004114.5 missense
Scores
8
8
1
Clinical Significance
Conservation
PhyloP100: 7.57
Genes affected
FGF13 (HGNC:3670): (fibroblast growth factor 13) The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF family members possess broad mitogenic and cell survival activities, and are involved in a variety of biological processes, including embryonic development, cell growth, morphogenesis, tissue repair, tumor growth, and invasion. This gene is located in a region on chromosome X, which is associated with Borjeson-Forssman-Lehmann syndrome (BFLS), making it a possible candidate gene for familial cases of the BFLS, and for other syndromal and nonspecific forms of X-linked cognitive disability mapping to this region. Alternative splicing of this gene at the 5' end results in several transcript variants encoding different isoforms with different N-termini. [provided by RefSeq, Nov 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.854
BS2
High Hemizygotes in GnomAdExome4 at 4 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FGF13 | NM_004114.5 | c.482G>A | p.Arg161His | missense_variant | 4/5 | ENST00000315930.11 | NP_004105.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FGF13 | ENST00000315930.11 | c.482G>A | p.Arg161His | missense_variant | 4/5 | 1 | NM_004114.5 | ENSP00000322390.6 |
Frequencies
GnomAD3 genomes AF: 0.00000899 AC: 1AN: 111292Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33508
GnomAD3 genomes
AF:
AC:
1
AN:
111292
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
33508
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000545 AC: 1AN: 183484Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 67924
GnomAD3 exomes
AF:
AC:
1
AN:
183484
Hom.:
AF XY:
AC XY:
0
AN XY:
67924
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000639 AC: 7AN: 1095668Hom.: 0 Cov.: 29 AF XY: 0.0000111 AC XY: 4AN XY: 361124
GnomAD4 exome
AF:
AC:
7
AN:
1095668
Hom.:
Cov.:
29
AF XY:
AC XY:
4
AN XY:
361124
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000899 AC: 1AN: 111292Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33508
GnomAD4 genome
AF:
AC:
1
AN:
111292
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
33508
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Developmental and epileptic encephalopathy, 90 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Diagnostics Services (NGS), CSIR - Centre For Cellular And Molecular Biology | Nov 29, 2024 | The c.482G>A variant is not present in publicly available population databases like 1000 Genomes, ExAC, EVS, Indian Exome Database and our internal database. This variant is present in gnomAD, at a low frequency. This variant has neither been published in literature in individuals affected with FGF13-related conditions nor reported to the clinical databases like ClinVar, Human Genome Mutation Database (HGMD) or OMIM, in any affected individuals. In-silico pathogenicity prediction programs like SIFT, PolyPhen-2, MutationTaster2, CADD etc predicted this variant to be likely deleterious however these predictions were not confirmed by published functional studies. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Uncertain
D;.;.;.;.;D
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;D;D;D;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D;D;D;D
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
M;.;.;.;.;.
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D;D;D;.;D;D
REVEL
Uncertain
Sift
Uncertain
D;D;D;.;D;D
Sift4G
Uncertain
D;D;D;D;D;.
Polyphen
D;D;.;.;.;.
Vest4
MutPred
Loss of MoRF binding (P = 0.0122);.;.;.;.;.;
MVP
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at